Problem statement: Answer the MCQ question.
Question: Which compound exhibits a -29.085% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a) CCOC(=O)N1CCN(c2c(N3CCN(C(=O)OCC)CC3)c(=O)c2=O)CC1
b) Cc1ccc(C(C)C)c(OCC(=O)NCC(c2cccs2)N2CCOCC2)c1
c) CC(C)(C)c1ccc(C(=O)NCc2nnc(SCC(=O)NC3CCCCC3)o2)cc1
d) CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
e) O=C(COC(=O)c1cc2ccccc2cc1O)NC(=O)NCc1ccco1
Answer: a. CCOC(=O)N1CCN(c2c(N3CCN(C(=O)OCC)CC3)c(=O)c2=O)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCOC(=O)N1CCN(c2c(N3CCN(C(=O)OCC)CC3)c(=O)c2=O)CC1
CCOC(=O)N1CCN(c2c(N3CCN(C(=O)OCC)CC3)c(=O)c2=O)CC1
ethyl4-[2-[4-(ethoxycarbonyl)piperazin-1-yl]-3,4-dioxocyclobuten-1-yl]piperazine-1-carboxylate